Trademark Details For NOOTROGEN (Serial Number 87540732)

  •  Home
  •  Print
NOOTROGEN
0
0
0
0
Serial Number  United States - USPTO 87540732
Registration Number 5578288
Mark
NOOTROGEN
Filing Date Jul-24-2017
Status
Registered  
SECTION 8-AC.. (701)
SECTION 8-ACCEPTED
Attorney Name
TTAB
0




005Pharmaceuticals

U.S Class(es): 006, 018, 044, 046, 051, 052

Class Status: Active

First Use: Jun-01-2017

First Use in Commerce: Jun-15-2017





Correspondences

NameJavier Gomez
AddressMarkavo.com 5473 Blair Rd Ste 100 PMB 72065 Dallas,TX 75231-4101

Prosecution History

DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Jul-27-2017NEW APPLICATION ENTERED   NWAPI
Jul-29-2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED   NWOSI
Sep-29-2017ASSIGNED TO EXAMINER   DOCKD
Oct-02-2017SUSPENSION LETTER WRITTEN   CNSLR
Oct-02-2017LETTER OF SUSPENSION E-MAILED   GNSLF
Oct-02-2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED   GNS3O
Apr-10-2018ASSIGNED TO LIE   ALIEA
Apr-10-2018REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED   RCSCS
Jun-12-2018TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED   ERSII
Jun-13-2018CORRESPONDENCE RECEIVED IN LAW OFFICE   CRFAI
Jun-13-2018TEAS/EMAIL CORRESPONDENCE ENTERED   TEMEI
Jun-14-2018APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAO
Jul-04-2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED   NONPE
Jul-24-2018PUBLISHED FOR OPPOSITION   PUBOA
Jul-24-2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED   NPUBE
Oct-09-2018REGISTERED-PRINCIPAL REGISTER   R.PRA
May-10-2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED   REAPI
May-10-2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED   ARAAI
May-15-2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP   ASGNI
Oct-09-2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED   REM1E
Dec-06-2023TEAS SECTION 8 RECEIVED   ES8RI
Feb-07-2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL   APREA
Feb-07-2024REGISTERED - SEC. 8 (6-YR) ACCEPTED   8.OKO
Feb-07-2024NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED   NAS8E